Safety and Efficacy of EXG102-031, a Novel AAV-Based Gene Therapy for Neovascular AMD

被引:0
|
作者
Wu, Zhenhua [1 ]
Dai, Li [1 ]
Song, Chunjuan [1 ]
Shen, Jikui [2 ]
Formica, Raquel [2 ]
Wang, Lijun [1 ]
Campochiaro, Peter A. [2 ]
Ye, Guo-Jie [1 ]
机构
[1] Exegenesis Bio Inc, Lower Gwynedd, PA USA
[2] Johns Hopkins Univ Hosp, Sch Med, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
1139
引用
收藏
页码:545 / 545
页数:1
相关论文
共 50 条
  • [41] Development of a novel AAV-based gene therapy in combination with tolerogenic nanoparticles for sustained treatment of ornithine transcarbamylase deficiency
    De Sabbata, G.
    Boisgerault, F.
    Guarnaccia, C.
    Bortolussi, G.
    Collaud, F.
    Iaconcig, A.
    Sola, M. L. S.
    Charles, S.
    Leborgne, C.
    Nicastro, E.
    Ilyinskii, P.
    Kishimoto, T. K.
    D'Antiga, L.
    Mingozzi, F.
    Muro, A. F.
    HUMAN GENE THERAPY, 2018, 29 (12) : A128 - A128
  • [42] Development of a universal extraction protocol for multiple AAV-based gene therapy shedding assays
    Wang, Z.
    Philipp, I.
    Qiu, X.
    Weitz, S.
    Armand, T.
    Uzgiris, A.
    HUMAN GENE THERAPY, 2019, 30 (11) : A114 - A114
  • [43] AAV-based gene therapy approaches for genetic forms of tauopathies and related neurogenetic disorders
    Al Kabbani, Mohamed Aghyad
    Wunderlich, Gilbert
    Koeler, Christoph
    Zempel, Hans
    BIOCELL, 2022, 46 (04) : 847 - 853
  • [44] Preclinical Evaluation of an AAV-Based Gene Therapy Approach for the Treatment of Friedreich Ataxia Cardiomyopathy
    Martelli, Alain
    Assaf, Basel T.
    Gooch, Renea
    Ma, Tiffany
    Whiteley, Laurence O.
    Bulawa, Christine
    MOLECULAR THERAPY, 2019, 27 (04) : 51 - 51
  • [45] Cerebellomedullary Cistern Delivery for AAV-Based Gene Therapy: A Technical Note for Nonhuman Primates
    Samaranch, Lluis
    Bringas, John
    Pivirotto, Philip
    Sebastian, Waldy San
    Forsayeth, John
    Bankiewicz, Krystof
    HUMAN GENE THERAPY METHODS, 2016, 27 (01) : 13 - 16
  • [46] High Expression Bioengineered Factor VIII Enables AAV-Based Gene Therapy of Hemophilia A
    Spencer, H. Trent
    Brown, Harrison C.
    Shields, Jordan E.
    Wright, J. Fraser
    Doering, Christopher B.
    MOLECULAR THERAPY, 2013, 21 : S253 - S253
  • [47] Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration
    Paula I. Fuller-Carter
    Hamed Basiri
    Alan R. Harvey
    Livia S. Carvalho
    BioDrugs, 2020, 34 : 763 - 781
  • [48] Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy
    Askou, Anne Louise
    Alsing, Sidsel
    Benckendorff, Josephine N. E.
    Holmgaard, Andreas
    Mikkelsen, Jacob Giehm
    Aagaard, Lars
    Bek, Toke
    Corydon, Thomas J.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 16 : 38 - 50
  • [49] AAV-Based Gene Therapy in a Mouse Model of Smith Lemli Opitz Syndrome (SLOS)
    Pasta, Saloni Y.
    Ting, Flora
    Tabron, Dorothy
    Sun, Sean
    Kadakia, Saurin
    Shackleton, Cedric
    Watson, Gordon
    MOLECULAR THERAPY, 2015, 23 : S147 - S147
  • [50] AAV-based liver-targeted gene therapy for MNGIE: proposal for a clinical trial
    van den Ameele, J.
    Cutting, E.
    Marti, R.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A95 - A95